medRxiv @medrxivpreprint@qoto.org

Durability of immune responses to the booster mRNA vaccination against COVID-19 https://www.medrxiv.org/content/10.1101/2022.12.02.22282921

Evaluating primary and booster vaccination prioritization strategies for COVID-19 by age and high-contact employment status using data from contact surveys https://www.medrxiv.org/content/10.1101/2022.12.02.22283040

Time scales of human monkeypox transmission in the Netherlands https://www.medrxiv.org/content/10.1101/2022.12.03.22283056

The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as A Case Study https://www.medrxiv.org/content/10.1101/2022.12.02.22283046

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCA-mutant ovarian cancer https://www.medrxiv.org/content/10.1101/2022.12.02.22283037

Death, Inequality, and the Pandemic in the Nation's Capital https://www.medrxiv.org/content/10.1101/2022.12.02.22283039

Stress and resilience during pregnancy: a comparative study between pregnant and non-pregnant women in Ethiopia https://www.medrxiv.org/content/10.1101/2022.12.01.22282980

Identifying patients requiring treatment for depression in the postpartum period from common electronic medical record data available antepartum using machine learning https://www.medrxiv.org/content/10.1101/2022.11.30.22282941

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines https://www.medrxiv.org/content/10.1101/2022.12.02.22282931

Analysis of the ARTIC V4 and V4.1 SARS-CoV-2 primers and their impact on the detection of Omicron BA.1 and BA.2 lineage defining mutations https://www.medrxiv.org/content/10.1101/2022.12.01.22282842

Clinical and real-world evaluation of a fingernail selfie smartphone app for noninvasive, individually-personalized estimation of blood hemoglobin levels https://www.medrxiv.org/content/10.1101/2022.12.01.22282972

Genetic risk factor clustering within and across neurodegenerative diseases https://www.medrxiv.org/content/10.1101/2022.12.01.22282945

A novel plasma proteomic computational model for predicting therapeutic benefit from immune checkpoint inhibitors in non-small cell lung cancer https://www.medrxiv.org/content/10.1101/2022.12.01.22282769

Cardiorenal Effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with validation against a target trial https://www.medrxiv.org/content/10.1101/2022.12.02.22282220

Evaluating the use of social contact data to produce age-specific forecasts of SARS-CoV-2 incidence https://www.medrxiv.org/content/10.1101/2022.12.02.22282935

Aortic valve stenosis induced occult hemoglobin release promotes endothelial dysfunction https://www.medrxiv.org/content/10.1101/2022.12.01.22282891

Circulation of Fluconazole-Resistant C. albicans, C. auris and C. parapsilosis Bloodstream Isolates Carrying Y132F, K143R or T220L Erg11p Substitutions in Colombia. https://www.medrxiv.org/content/10.1101/2022.11.30.22282939

Associations between area-level health-related social factor indices and risk of acute COVID-19: An EHR-based cohort study from the RECOVER program https://www.medrxiv.org/content/10.1101/2022.12.02.22282944

Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico https://www.medrxiv.org/content/10.1101/2022.12.02.22282981

Battle of Polio eradication in the Western Pacific Region in the transition to COVID-19 endemicity https://www.medrxiv.org/content/10.1101/2022.11.30.22282954